Tel Aviv University Professor Jonathan Gershoni has been granted a US patent for technology to develop a vaccine for COVID-19. The vaccine targets the coronavirus’s Achilles’ heel, its Receptor Binding Motif (RBM), which the virus uses to bind to and infect a target cell.
US patent for coronavirus vaccine
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.